- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01210729
Mechanical Recanalization With Flow Restoration in Acute Ischemic Stroke (ReFlow)
December 1, 2011 updated by: Universität des Saarlandes
Mechanical Recanalization With Flow Restoration in Acute Ischemic Stroke (ReFlow Study)
The objective of this study is to collect data on the use of the SOLITAIR FR device for treatment of acute ischemic stroke with large artery occlusion i.e. to investigate, whether the application of SOLITAIR is a safe and feasible method for interventional recanalization of large vessels with favorable patient outcome in acute stroke therapy.
Study Overview
Study Type
Interventional
Enrollment (Anticipated)
40
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Saarland
-
Homburg, Saarland, Germany, 66424
- Department of Diagnostic and Interventional Neuroradiology
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 85 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age 18-85 years
- Acute ischemic stroke with occlusion if ICA, MCA, VA or BA (TICI 0 or 1 flow) within the first 6 hours
Exclusion Criteria:
- Rapidly improving neurological signs
- NHISS>30 or coma
- Female patients, who are pregnant or lactating
- Use of warfarin anticoagulation with INR > 1.5
- Platelet count < 30,000
- Glucose < 50 mg/dL
- Life expectancy of less than 90 days
- Computed tomography (CT) or Magnetic Resonance Imaging (MRI) evidence of hemorrhage on presentation
- CT showing hypodensity on presentation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Overall frequency of favourable clinical outcome (modified Rankin Scale 0 to 2), and unfavourable clinical outcome or death (modified Rankin Scale 3 to 6)
Time Frame: Day 90
|
Day 90
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
All causes of mortality
Time Frame: Day 90
|
Day 90
|
|
Arterial recanalization of occluded target vessel measured by Thrombolysis in Cerebral Infarction (TICI)score of 2b or 3 following the use of the SOLITAIRE FR Device
Time Frame: Day 0
|
Day 0
|
|
Excellent functional clinical outcome (modified Rankin Scale 0 or 1)
Time Frame: Day 90
|
Day 90
|
|
Proportion of patients with rapid neurological improvement (more than 4 points on the NIHSS) during the first 24 hours after treatment.
Time Frame: Day 1
|
Day 1
|
|
Symptomatic intracranial haemorrhages up to 24 hours after treatment defined as homogeneous areas of haemorrhage, with or without mass effect or intraventricular extension with neurological deterioration
Time Frame: Day 1
|
Day 1
|
|
Time between arterial puncture and Flow Restoration
Time Frame: Day 0
|
Day 0
|
|
Time between arterial puncture and TICI 2b or 3 recanalization
Time Frame: Day 0
|
Day 0
|
|
Number of SOLITAIRE device runs until recanalization
Time Frame: Day 0
|
Day 0
|
|
Number of patients with and degree of stenosis in the treated artery 90 days after recanalization with SOLITAIRE
Time Frame: Day 90
|
Day 90
|
|
Number of patients in which thrombus material was preserved
Time Frame: Day 0
|
Day 0
|
|
Histological examination of the thrombus material in correlation with TICI 2b or 3 recanalization and favorable clinical outcome
Time Frame: Day 1
|
Day 1
|
|
Overall frequency of modified Rankin Scale 0 to 2 at 30 days
Time Frame: Day 30
|
Day 30
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Wolfgang Reith, MD, Saarland University Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Papanagiotou P, Roth C, Walter S, Behnke S, Politi M, Fassbender K, Haass A, Reith W. Treatment of acute cerebral artery occlusion with a fully recoverable intracranial stent: a new technique. Circulation. 2010 Jun 15;121(23):2605-6. doi: 10.1161/CIRCULATIONAHA.110.948166. No abstract available.
- Roth C, Papanagiotou P, Behnke S, Walter S, Haass A, Becker C, Fassbender K, Politi M, Korner H, Romann MS, Reith W. Stent-assisted mechanical recanalization for treatment of acute intracerebral artery occlusions. Stroke. 2010 Nov;41(11):2559-67. doi: 10.1161/STROKEAHA.110.592071. Epub 2010 Oct 14.
- Papanagiotou P, Roth C, Walter S, Behnke S, Grunwald IQ, Viera J, Politi M, Korner H, Kostopoulos P, Haass A, Fassbender K, Reith W. Carotid artery stenting in acute stroke. J Am Coll Cardiol. 2011 Nov 29;58(23):2363-9. doi: 10.1016/j.jacc.2011.08.044.
- Papanagiotou P, Roth C, Reith W. Letter by Papanagiotou et Al regarding article, "percutaneous vascular interventions for acute ischemic stroke". Stroke. 2011 Sep;42(9):e545; author reply e546. doi: 10.1161/STROKEAHA.111.620989. Epub 2011 Jul 14. No abstract available.
- Roth C, Reith W, Walter S, Behnke S, Kettner M, Viera J, Yilmaz U, Alexandrou M, Politi M, Kostopoulos P, Korner H, Krick C, Haass A, Fassbender K, Papanagiotou P. Mechanical recanalization with flow restoration in acute ischemic stroke: the ReFlow (mechanical recanalization with flow restoration in acute ischemic stroke) study. JACC Cardiovasc Interv. 2013 Apr;6(4):386-91. doi: 10.1016/j.jcin.2012.11.013. Epub 2013 Mar 20.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2010
Primary Completion (Actual)
November 1, 2011
Study Completion (Actual)
November 1, 2011
Study Registration Dates
First Submitted
September 27, 2010
First Submitted That Met QC Criteria
September 27, 2010
First Posted (Estimate)
September 28, 2010
Study Record Updates
Last Update Posted (Estimate)
December 2, 2011
Last Update Submitted That Met QC Criteria
December 1, 2011
Last Verified
September 1, 2010
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ReFlow01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Stroke
-
University Hospital HeidelbergCompletedAcute Ischemic Stroke | Acute Ischemic Stroke AIS | Acute Ischemic Stroke PatientsGermany
-
Capital Medical UniversityCompletedAcute Ischaemic Stroke | Stroke-associated PneumoniaChina
-
University of CalgaryThe George Institute for Global Health, AustraliaRecruitingAcute Ischemic Stroke AIS | Stroke, Acute, Stroke Ischemic | Stroke AcuteCanada, Australia
-
Chinese University of Hong KongThe Hong Kong Polytechnic University; City University of Hong Kong; Hong Kong... and other collaboratorsRecruitingAcute Ischemic Stroke | Acute Stroke | Acute Stroke InterventionHong Kong
-
Prof. Dr. Jan LimanUniversity Hospital, Basel, Switzerland; Klinikum Nürnberg; Deutsche ForschungegemeinschaftRecruitingHemorrhagic Stroke, Intracerebral | Acute Ischemic Stroke AIS | Stroke AcuteSwitzerland, Germany
-
University of MiamiNo longer availableStroke, Ischemic | Stroke, Acute | Mesenchymal Stem Cells | Acute Ischemic Stroke | Stroke/Brain AttackUnited States
-
Cidat, S.A. de C.V.El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco SuarezUnknownStroke | Stroke, Acute | Cerebral Stroke | Cerebrovascular Stroke | Cerebrovascular Accident, AcuteMexico
-
Hospital Universitari Vall d'Hebron Research InstituteMethinks Software SLRecruitingStroke | Ischemic Stroke, Acute | Thrombectomy | Stroke AcuteSpain
-
NeurotechnikaSamara State Medical University; Samara Regional Clinical Hospital V.D. SeredavinRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Acute | Stroke, Acute, Ischemic | Stroke with HemiparesisRussian Federation
-
Southwest Hospital, ChinaRecruitingAcute Ischemic Stroke PatientsChina
Clinical Trials on Solitaire FR, ev3
-
Jinling Hospital, ChinaCompleted
-
Ministry of Science and Technology of the People´s...CompletedAcute Ischemic StrokeChina
-
Ministry of Science and Technology of the People´s...UnknownCerebrovascular Disorders | Acute Ischemic Stroke | Large Vessel OcclusionChina
-
Medtronic Neurovascular Clinical Affairsev3 InternationalCompleted
-
Suzhou Zenith Vascular Scitech Co., Ltd.CompletedAcute Ischemic Stroke | Large Vessel Occlusion | AIS | ThrombectomyChina
-
Xuanwu Hospital, BeijingRecruitingStroke | Acute Ischemic StrokeChina
-
Fundacio Ictus Malaltia VascularMedtronic - MITGTerminated
-
Gregory W AlbersMedical University of South Carolina; National Institute of Neurological Disorders... and other collaboratorsTerminatedCerebral Infarction | Stroke, AcuteUnited States
-
Hospital de Clinicas de Porto AlegreMinistry of Health, Brazil; Medtronic; Penumbra Inc.; Brainomix Limited; iSchemaView...Completed
-
Therese HössjerUppsala University; Uppsala University HospitalRecruitingGranuloma | Food Intolerance | Gastrostomy Complications | Gastrostomy SizeSweden